Federal funding to support ongoing research in preventing and treating Alzheimer’s disease
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin today announced $3 million in federal grant funding from the National Institutes of Health (NIH) for the Wisconsin Alzheimer’s Disease Research Center (WADRC) at the University of Wisconsin-Madison.
As a member of the Senate Appropriations Committee, Senator Baldwin helped secure federal investments in ongoing research to prevent and treat Alzheimer’s in Wisconsin and around the nation.
“Alzheimer’s continues to put enormous demands on our health care system and the Wisconsinites who care for those with the disease,” said Senator Baldwin. “This federal funding will enhance the work of the Wisconsin Alzheimer’s Disease Research Center so they can continue their innovative research on preventative treatment options to help slow, and eventually stop, the progression of Alzheimer’s disease.”
Senator Baldwin has been a strong supporter of Wisconsin research, science and innovation and has worked to secure funding for NIH to help support the efforts of research leaders like the University of Wisconsin-Madison. WADRC will use this federal funding to focus on prevention research that will help slow the impacts of Alzheimer’s disease.
More than five million Americans live with Alzheimer’s disease and the number is projected to grow by millions in the next decade. This devastating disease also places huge demands on caregivers and the health care system. This federal funding will help Wisconsin continue to be a leader in accelerating groundbreaking research on Alzheimer’s and other diseases.